James Huang

Filings by James Huang span 4 companies, the busiest being Alaunos Therapeutics, Inc., CASI Pharmaceuticals, Inc. and Windtree Therapeutics Inc. Between 4 March 2021 and 29 May 2026, the trades on record add up to 13 filings.

Every open-market trade on record is a purchase: 8 purchases worth €1.2M, and no sale. The totals do not cover 2 filings with an undisclosed amount. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 5 share grants. In 2026 alone, the filings show 2 purchases and no sales.

Half of the purchases are above €119k and half below. Of 6 purchases, 1 formed part of a group of insiders buying within 30 days of each other. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.

Most recently, on 2 June 2026, the filings show an open-market purchase worth €320k in Connect Biopharma Holdings Ltd. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.